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To the Editor,
We would like to thank Dr. Mbagaya for his interest and comments on our recent study which estimated the within-and between-person coefficients of variation of high sensitivity cardiac troponin T (hs-cTnT) in stable haemodialysis and peritoneal dialysis patients [1] .
While hs-cTnT measurements in the study cohort ranged from 8 to 241 ng/L, the hs-cTnT frequency distribution demonstrated a right skew and is therefore better summarized using the median (34 ng/L) and interquartile range (24-54 ng/L). The total imprecision of the hs-cTnT assay at these concentrations approximates that reported in our study [2] and, as such, the reported reference change values are applicable to the vast majority of dialysis patients encountered in clinical practice. The interpretation of serial hs-cTnT measurements in the very small minority of dialysis patients with a baseline hs-cTnT concentration < 14 ng/L should be guided by standard recommendations which require a serial change in shortterm hs-cTnT concentrations with at least one measurement exceeding the assay's upper reference limit in an appropriate clinical context in order to make a diagnosis of acute myocardial injury [3, 4] .
Changes in hs-cTnT concentrations across a haemodialysis session are related to dialyser membrane ultrafiltration coefficient [5] . The design of our study purposely sought to eliminate such pre-analytical factors by standardising the timing of sample collection to allow accurate estimation of the within-person coefficient of variation. Variation in hs-cTnT concentrations related to dialyser clearance are modest (12%) and significantly smaller than the 99% reference change values reported in our study (-25% and +33%) and therefore unlikely to be confused with true myocardial injury in clinical practice [1, 6] . Cardiac stunning describes reversible regional wall abnormalities that occur in a small proportion of haemodialysis patients prone to intradialytic hypotension and has been associated with higher baseline cardiac troponin concentrations [7] . However, cardiac stunning does not cause a dynamic change in troponin concentrations and therefore should not impact on the interpretation of serial hs-cTnT concentrations [8] .
We agree that further research is required to establish the magnitude of change in serial hs-cTnT concentrations associated with adverse outcomes in dialysis patients.
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